Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer

Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic inflammatory response to irritants, frequently to tobacco smoke. The progression of COPD from early onset to advanced disease...

Full description

Bibliographic Details
Main Authors: Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Á. Balog, László G. Puskás, Gábor J. Szebeni
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/13/2889
_version_ 1797528403533889536
author Klára Szalontai
Nikolett Gémes
József Furák
Tünde Varga
Patrícia Neuperger
József Á. Balog
László G. Puskás
Gábor J. Szebeni
author_facet Klára Szalontai
Nikolett Gémes
József Furák
Tünde Varga
Patrícia Neuperger
József Á. Balog
László G. Puskás
Gábor J. Szebeni
author_sort Klára Szalontai
collection DOAJ
description Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic inflammatory response to irritants, frequently to tobacco smoke. The progression of COPD from early onset to advanced disease leads to the loss of the alveolar wall, pulmonary hypertension, and fibrosis of the respiratory epithelium. Here, we focus on the epidemiology, progression, and biomarkers of COPD with a particular connection to lung cancer. Dissecting the cellular and molecular players in the progression of the disease, we aim to shed light on the role of smoking, which is responsible for the disease, or at least for the more severe symptoms and worse patient outcomes. We summarize the inflammatory conditions, as well as the role of EMT and fibroblasts in establishing a cancer-prone microenvironment, i.e., the soil for ‘COPD-derived’ lung cancer. We highlight that the major health problem of COPD can be alleviated via smoking cessation, early diagnosis, and abandonment of the usage of biomass fuels on a global basis.
first_indexed 2024-03-10T09:57:51Z
format Article
id doaj.art-8144b41aca7147328250851e16ae8cb7
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T09:57:51Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-8144b41aca7147328250851e16ae8cb72023-11-22T02:10:03ZengMDPI AGJournal of Clinical Medicine2077-03832021-06-011013288910.3390/jcm10132889Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung CancerKlára Szalontai0Nikolett Gémes1József Furák2Tünde Varga3Patrícia Neuperger4József Á. Balog5László G. Puskás6Gábor J. Szebeni7Csongrád County Hospital of Chest Diseases, Alkotmány u. 36., H6772 Deszk, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryDepartment of Surgery, University of Szeged, Semmelweis u. 8., H6725 Szeged, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryLaboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62., H6726 Szeged, HungaryChronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic inflammatory response to irritants, frequently to tobacco smoke. The progression of COPD from early onset to advanced disease leads to the loss of the alveolar wall, pulmonary hypertension, and fibrosis of the respiratory epithelium. Here, we focus on the epidemiology, progression, and biomarkers of COPD with a particular connection to lung cancer. Dissecting the cellular and molecular players in the progression of the disease, we aim to shed light on the role of smoking, which is responsible for the disease, or at least for the more severe symptoms and worse patient outcomes. We summarize the inflammatory conditions, as well as the role of EMT and fibroblasts in establishing a cancer-prone microenvironment, i.e., the soil for ‘COPD-derived’ lung cancer. We highlight that the major health problem of COPD can be alleviated via smoking cessation, early diagnosis, and abandonment of the usage of biomass fuels on a global basis.https://www.mdpi.com/2077-0383/10/13/2889COPDchronic airway inflammationsmokinglung cancer
spellingShingle Klára Szalontai
Nikolett Gémes
József Furák
Tünde Varga
Patrícia Neuperger
József Á. Balog
László G. Puskás
Gábor J. Szebeni
Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
Journal of Clinical Medicine
COPD
chronic airway inflammation
smoking
lung cancer
title Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
title_full Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
title_fullStr Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
title_full_unstemmed Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
title_short Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
title_sort chronic obstructive pulmonary disease epidemiology biomarkers and paving the way to lung cancer
topic COPD
chronic airway inflammation
smoking
lung cancer
url https://www.mdpi.com/2077-0383/10/13/2889
work_keys_str_mv AT klaraszalontai chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT nikolettgemes chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT jozseffurak chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT tundevarga chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT patricianeuperger chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT jozsefabalog chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT laszlogpuskas chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer
AT gaborjszebeni chronicobstructivepulmonarydiseaseepidemiologybiomarkersandpavingthewaytolungcancer